Synthelis is a French biotech company specialized in production, purification and characterization of membrane proteins and other difficult-to-express proteins such as ion channel, membrane transporter, GPCR, membrane enzyme and antigen.
Mymetics is developing preventative vaccines using both virosomes as an effective adjuvant and vaccine delivery method, and an innovative antigen design to generate mucosal antibodies.
XstalBio tackles challenging biologic formulations (required dosing too frequent, controlled release of API required, competitors hold blocking formulation patents, better adjuvant needed for target antigens, etc… ).
Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on a patented formulation providing controlled and prolonged exposure of antigens and adjuvant to the immune system : DepoVax.
